[Which role today for intra-aortic balloon counterpulsation?]

Area of Science:

• Cardiology
• Medical Devices
• Mechanical Circulatory Support

Background:

• The intra-aortic balloon pump (IABP) is a percutaneous cardiac assist device known for ease of implantation and low complication rates.
• It functions by reducing afterload and preload, increasing mean arterial pressure and coronary perfusion.
• IABP is frequently employed in cardiogenic shock and acute myocardial infarction despite limited high-level evidence of efficacy.

Purpose of the Study:

• To review the current evidence and clinical applications of the intra-aortic balloon pump (IABP).
• To evaluate the efficacy of IABP in various cardiovascular settings based on recent clinical trials and guidelines.
• To discuss the evolving role of IABP in contemporary cardiology.

Main Methods:

• Review of major randomized clinical trials, including IABP-SHOCK II and CRISP-AMI.
• Analysis of international guideline recommendations regarding IABP use.
• Examination of evidence for IABP in specific scenarios like percutaneous coronary interventions and surgical revascularization.

Main Results:

• The IABP-SHOCK II trial did not demonstrate a benefit of IABP in cardiogenic shock.
• The CRISP-AMI trial showed no reduction in ischemic area with routine IABP use in anterior myocardial infarction.
• Guidelines do not support routine IABP use in acute myocardial infarction with cardiogenic shock but suggest it for mechanical complications or myocarditis.

Conclusions:

• International guidelines recommend against the routine use of intra-aortic balloon pumps (IABP) in acute myocardial infarction complicated by cardiogenic shock.
• IABP may be beneficial in specific situations, such as acute heart failure with mechanical complications or acute myocarditis.
• Despite limited evidence, IABP remains a widely used mechanical circulatory support device in cardiology.